Clinical Study
Effect of High-Flow Nasal Cannula versus Conventional Oxygen Therapy for Patients with Thoracoscopic Lobectomy after Extubation
Table 1
Demographic characteristics of the patients who participated in the study (mean
SD).
| | Characteristics | HFNCG () | COG () | |
| | Age, yrs | 56.31 7.03 | 55.82 7.92 | 0.732 | | Male gender, (%) | 30 (53.57) | 28 (51.85) | 1.000 | | BMI, kg/m2 | 26.32 4.73 | 25.19 5.02 | 0.226 | | APACHE II | 26.32 4.73 | 25.19 5.02 | 0.226 | | ARISCAT | 31.12 3.74 | 32.36 3.08 | 0.071 | | COPD, (%) | 8 (14.29) | 7 (12.96) | 0.840 | | Asthma, (%) | 5 (8.93) | 4 (7.41) | 1.000 | | Smoking history, (%) | 12 (21.43) | 8 (14.81) | 0.369 | | Hemoglobin, g/L | 108.29 17.31 | 105.43 22.06 | 0.450 | | Lactate, mmol/L | 0.32 0.07 | 0.33 0.06 | 0.424 | | Respiratory, /min | 18.43 3.45 | 17.98 3.87 | 0.521 | | PaO2, mmHg | 95.37 12.42 | 92.59 18.49 | 0.355 | | PaCO2, mmHg | 41.73 6.33 | 43.52 4.93 | 0.102 | | PaO2/FiO2, mmHg | 350.35 33.87 | 340.98 40.65 | 0.191 | | SaO2/FiO2 | 210.37 52.77 | 222.51 48.65 | 0.213 | | FRC, L | 2.08 0.32 | 2.12 0.41 | 0.567 | | FEV1/FVC, % | 78.63 11.52 | 75.52 13.45 | 0.195 | | Postsurgical ventilation durations, h | 2.13 0.43 | 2.18 0.32 | 0.492 |
|
|
